Results 211 to 220 of about 154,147 (272)

Cost-effectiveness analysis of oral antiviral therapy in patients with indeterminate chronic hepatitis B infection. [PDF]

Transl Gastroenterol Hepatol
Zhuo HY, Lin Y, Song HW, Hong MZ, Yao LF, Pan JS.   +5 more
europepmc   +1 more source

Methodological challenges in Dutch HTA of non-oncological orphan drugs: a retrospective analysis and price comparison using different pricing models. [PDF]

Orphanet J Rare Dis
Walraven J, Kaveh M, Uyl-de Groot C.
europepmc   +1 more source

The Economic and Clinical Impact of Recurring Automated Red Blood Cell Exchange to Manage Sickle Cell Disease in the UK. [PDF]

Pharmacoecon Open
Medland SM, Bainbridge J, Cawson M, Mealing SJ, Yudina A, Eastwood I, de Kreuk A, Besser M, Tsouana E.   +8 more
europepmc   +1 more source

Cost-Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn's Disease. [PDF]

Pharmacoeconomics
Versteegh MM, Huygens SA, Bermejo I, Grimm S, Pierik M, Römkens T, van Schaik F, Wahab P.   +7 more
europepmc   +1 more source

Lifetime cost-effectiveness of lecanemab for early Alzheimer's disease. [PDF]

Front Public Health
Jiang X, Lv G, Mendes ME, Wu J, Yuan J, Lu ZK.   +5 more
europepmc   +1 more source

Cost-effectiveness of semaglutide 2.4 mg versus liraglutide 3 mg for the treatment of obesity in Greece. [PDF]

Front Public Health
Papantoniou P, Maniadakis N.
europepmc   +1 more source